🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open label, randomized, single-center, single-dose, two-treatment, two-p...
Status
Completed
Location
Bioanalytical Systems, Inc
Start Date
2005-04
Trial ID
NCT00776022
Treatments Being Tested
To determine the pharmacokinetics and bioequivalence of cetirizine hydrochl...
Status
Completed
Location
AAIPharma Inc.- AAI Clinic
Start Date
2006-08
Trial ID
NCT00863902
Treatments Being Tested
The primary objective of this study was to determine whether children ages ...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00780403
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Novum Pharmaceutical Research Services
Start Date
2002-11
Trial ID
NCT00649857
Treatments Being Tested
To determine the pharmacokinetics and bioequivalence of cetirizine hydrochl...
Status
Completed
Location
AAIPharma Inc.- AAI Clinic
Start Date
2006-08
Trial ID
NCT00864279
Treatments Being Tested
This was a randomized, open-label, 2-way cross-over study, comparing deslor...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00779116
Treatments Being Tested
An open label, randomized, single-center, single-dose, two-treatment, two-p...
Status
Completed
Location
Bioanalytical Systems, Inc.
Start Date
2004-10
Trial ID
NCT00776139
Treatments Being Tested
The purpose of this study is to determine and compare the amount of study d...
Status
Completed
Location
Algorithme (An altascience Company)
Start Date
2018-12-11
Trial ID
NCT03772158
Treatments Being Tested
"The objective of this study was to investigate the bioequivalence of Mylan...
Status
Completed
Location
Novum Pharmaceutical Research Services
Start Date
2002-11
Trial ID
NCT00650065
Treatments Being Tested